The Integrated Genomics Operation (IGO) core enables basic, clinical, and translational science by providing a broad range of services and expertise to investigators interested in evaluating gene expression, chromosome structure, and nucleotide sequence. Our services are comprehensive, rapid, and user-friendly. Through the centralized management of all sequencing activities at MSK, the core empowers scientists with an array of technological options and the most efficient and cost-effective means of performing high-throughput genomics.
Company Details
- Address
- 1250 First Avenue, New York,new York 10065,united States
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Genomics, Transcriptomics, Sequencing, Spatial Transcriptomics, Whole Exome Sequencing, Whole Genome Sequencing, ATAC-Seq, ChIP-Seq, Single Cell RNA-Seq, DNA Extraction, RNA Extraction, Long-read sequencing.
- HQ
- New York, New York
Integrated Genomics Operation Questions
Integrated Genomics Operation's website is https://www.mskcc.org/research/ski/core-facilities/integrated-genomics-operation-igo
Integrated Genomics Operation's LinkedIn profile is https://www.linkedin.com/company/igo-mskcc
Integrated Genomics Operation's industry is
Research Services
Integrated Genomics Operation's top competitors are
Memorial Sloan Kettering Cancer Center,
Decode Genetics,
Vexas Foundation Inc,
Kara Lab,
Chan Zuckerberg Biohub Network,
American Society For Cell Biology (Ascb),
Highervets,
Aviation Secure Inc.,
Cytolytics,
Flow Cytometry Core Facility.
Integrated Genomics Operation's categories are Research Services
